US Tech 100

19,804.00

0.64%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OPGN

OpGen (OPGN)

OpGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OPGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
10/12/2023	12:32PM	GlobeNewswire Inc.	OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds	NASDAQ:OPGN	OpGen Inc
10/11/2023	4:40PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
10/11/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
09/28/2023	4:24PM	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:OPGN	OpGen Inc
09/08/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
09/07/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
08/14/2023	8:45AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OPGN	OpGen Inc
08/10/2023	4:31PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
08/10/2023	4:15PM	GlobeNewswire Inc.	OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
08/07/2023	7:30AM	GlobeNewswire Inc.	OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering	NASDAQ:OPGN	OpGen Inc
08/03/2023	8:00AM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement	NASDAQ:OPGN	OpGen Inc
08/03/2023	7:30AM	GlobeNewswire Inc.	OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time	NASDAQ:OPGN	OpGen Inc
08/01/2023	9:40AM	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:OPGN	OpGen Inc
07/21/2023	4:55PM	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:OPGN	OpGen Inc
07/19/2023	7:30AM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND	NASDAQ:OPGN	OpGen Inc
07/14/2023	4:30PM	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:OPGN	OpGen Inc
07/05/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
06/30/2023	4:30PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
06/26/2023	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
06/26/2023	7:30AM	GlobeNewswire Inc.	OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe	NASDAQ:OPGN	OpGen Inc
06/22/2023	7:30AM	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments	NASDAQ:OPGN	OpGen Inc
06/20/2023	7:30AM	GlobeNewswire Inc.	OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference	NASDAQ:OPGN	OpGen Inc
06/09/2023	4:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
06/09/2023	4:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
06/09/2023	4:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OPGN	OpGen Inc
06/09/2023	4:31PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OPGN	OpGen Inc
05/22/2023	5:00PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OPGN	OpGen Inc
05/15/2023	4:15PM	GlobeNewswire Inc.	OpGen Reports First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
05/15/2023	2:42PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OPGN	OpGen Inc
05/08/2023	7:30AM	GlobeNewswire Inc.	OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time	NASDAQ:OPGN	OpGen Inc